BDBM339913 3-Ethoxypropyl 5-({(3R)-1-[(trans-4-{(1S)-1-[(tert-butoxycarbonyl)amino]-2-fluoroethyl}cyclohexyl)carbonyl]-3-phenyl-L-prolyl}amino)-1H-indole-2-carboxylate::US9758480, 141

SMILES N[C@H](CF)[C@H]1CC[C@H](C(=O)N2CC[C@@H](C3CCCCC3)[C@H]2C(=O)Nc2ccc3c(c2)C=C(C(=O)OCC2CCOCC2)C3)CC1

InChI Key InChIKey=MRZVNOYQBUDOJN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 339913   

TargetCoagulation factor XI(Human)
Sumitomo Dainippon Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 339913BDBM339913(US9758480, 141 | 3-Ethoxypropyl 5-({(3R)-1-[(trans...)
Affinity DataIC50: 3.45E+3nMAssay Description:0.35 μg/mL human FXIa was allowed to react with a substrate and a test compound in a 30 mmol/L HEPES buffer solution (pH 7.4) that contained 145...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2019
Entry Details
US Patent